ID   CHSTB_HUMAN             Reviewed;         352 AA.
AC   Q9NPF2; A8K4F8; Q9NXY6; Q9NY36;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 129.
DE   RecName: Full=Carbohydrate sulfotransferase 11;
DE            EC=2.8.2.5;
DE   AltName: Full=Chondroitin 4-O-sulfotransferase 1;
DE   AltName: Full=Chondroitin 4-sulfotransferase 1;
DE            Short=C4S-1;
DE            Short=C4ST-1;
DE            Short=C4ST1;
GN   Name=CHST11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=11056388; DOI=10.1093/oxfordjournals.jbchem.a022813;
RA   Okuda T., Mita S., Yamauchi S., Matsubara T., Yagi F., Yamamori D.,
RA   Fukuta M., Kuroiwa A., Matsuda Y., Habuchi O.;
RT   "Molecular cloning, expression, and chromosomal mapping of human
RT   chondroitin 4-sulfotransferase, whose expression pattern in human
RT   tissues is different from that of chondroitin 6-sulfotransferase.";
RL   J. Biochem. 128:763-770(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10781601; DOI=10.1074/jbc.M002443200;
RA   Hiraoka N., Nakagawa H., Ong E., Akama O.T., Fukuda N.M., Fukuda M.;
RT   "Molecular cloning and expression of two distinct human chondroitin 4-
RT   O-sulfotransferases that belong to the HNK-1 sulfotransferase gene
RT   family.";
RL   J. Biol. Chem. 275:20188-20196(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Xia G., Evers M.R., Schachner M.;
RT   "Cloning and expression of a human chondroitin-4-sulfotransferase
RT   similar to members of the HNK-1 sulfotransferase family.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBSTRATE SPECIFICITY.
RX   PubMed=12847091; DOI=10.1074/jbc.M306044200;
RA   Mikami T., Mizumoto S., Kago N., Kitagawa H., Sugahara K.;
RT   "Specificities of three distinct human chondroitin/dermatan N-
RT   acetylgalactosamine 4-O-sulfotransferases demonstrated using partially
RT   desulfated dermatan sulfate as an acceptor. Implication of
RT   differential roles in dermatan sulfate biosynthesis.";
RL   J. Biol. Chem. 278:36115-36127(2003).
RN   [8]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH IGH.
RX   PubMed=15273723; DOI=10.1038/sj.onc.1207934;
RA   Schmidt H.H., Dyomin V.G., Palanisamy N., Itoyama T., Nanjangud G.,
RA   Pirc-Danoewinata H., Haas O.A., Chaganti R.S.K.;
RT   "Deregulation of the carbohydrate (chondroitin 4) sulfotransferase 11
RT   (CHST11) gene in a B-cell chronic lymphocytic leukemia with a
RT   t(12;14)(q23;q32).";
RL   Oncogene 23:6991-6996(2004).
RN   [9]
RP   BIOPHYSICOCHEMICAL PROPERTIES, GLYCOSYLATION, AND MUTAGENESIS OF
RP   LYS-125; ASN-205; ASN-223 AND ASN-342.
RX   PubMed=15628971; DOI=10.1042/BJ20041573;
RA   Yusa A., Kitajima K., Habuchi O.;
RT   "N-linked oligosaccharides are required to produce and stabilize the
RT   active form of chondroitin 4-sulphotransferase-1.";
RL   Biochem. J. 388:115-121(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Catalyzes the transfer of sulfate to position 4 of the
CC       N-acetylgalactosamine (GalNAc) residue of chondroitin. Chondroitin
CC       sulfate constitutes the predominant proteoglycan present in
CC       cartilage and is distributed on the surfaces of many cells and
CC       extracellular matrices. Can also sulfate Gal residues in
CC       desulfated dermatan sulfate. Preferentially sulfates in
CC       GlcA->GalNAc unit than in IdoA->GalNAc unit. Does not form 4, 6-
CC       di-O-sulfated GalNAc when chondroitin sulfate C is used as an
CC       acceptor.
CC   -!- CATALYTIC ACTIVITY: 3'-phosphoadenylyl sulfate + chondroitin =
CC       adenosine 3',5'-bisphosphate + chondroitin 4'-sulfate.
CC       {ECO:0000269|PubMed:10781601, ECO:0000269|PubMed:11056388}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.5 uM for PAPS {ECO:0000269|PubMed:15628971};
CC         KM=2.1 mM for chondroitin {ECO:0000269|PubMed:15628971};
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NPF2-1; Sequence=Displayed;
CC       Name=2; Synonyms=C4S-1A;
CC         IsoId=Q9NPF2-2; Sequence=VSP_012992;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in spleen,
CC       thymus, bone marrow, peripheral blood leukocytes, lymph node,
CC       heart, brain, lung and placenta. {ECO:0000269|PubMed:10781601,
CC       ECO:0000269|PubMed:11056388}.
CC   -!- PTM: N-glycosylated; required for activity and stability.
CC       {ECO:0000269|PubMed:15628971}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CHST11 is found
CC       in B-cell chronic lymphocytic leukemias. Translocation
CC       t(12;14)(q23;q32) with IgH. {ECO:0000269|PubMed:15273723}.
CC   -!- SIMILARITY: Belongs to the sulfotransferase 2 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB042326; BAA95485.1; -; mRNA.
DR   EMBL; AF239820; AAF81691.1; -; mRNA.
DR   EMBL; AJ269537; CAB87380.1; -; mRNA.
DR   EMBL; AJ289134; CAB92134.1; -; mRNA.
DR   EMBL; AK290923; BAF83612.1; -; mRNA.
DR   EMBL; CH471054; EAW97748.1; -; Genomic_DNA.
DR   EMBL; BC013315; AAH13315.1; -; mRNA.
DR   CCDS; CCDS55878.1; -. [Q9NPF2-2]
DR   CCDS; CCDS9099.1; -. [Q9NPF2-1]
DR   PIR; JC7525; JC7525.
DR   RefSeq; NP_001167453.1; NM_001173982.1. [Q9NPF2-2]
DR   RefSeq; NP_060883.1; NM_018413.5. [Q9NPF2-1]
DR   UniGene; Hs.17569; -.
DR   ProteinModelPortal; Q9NPF2; -.
DR   BioGrid; 119084; 4.
DR   STRING; 9606.ENSP00000305725; -.
DR   PhosphoSitePlus; Q9NPF2; -.
DR   SwissPalm; Q9NPF2; -.
DR   BioMuta; CHST11; -.
DR   DMDM; 61212137; -.
DR   EPD; Q9NPF2; -.
DR   MaxQB; Q9NPF2; -.
DR   PaxDb; Q9NPF2; -.
DR   PeptideAtlas; Q9NPF2; -.
DR   PRIDE; Q9NPF2; -.
DR   DNASU; 50515; -.
DR   Ensembl; ENST00000303694; ENSP00000305725; ENSG00000171310. [Q9NPF2-1]
DR   Ensembl; ENST00000549260; ENSP00000450004; ENSG00000171310. [Q9NPF2-2]
DR   GeneID; 50515; -.
DR   KEGG; hsa:50515; -.
DR   UCSC; uc001tky.4; human. [Q9NPF2-1]
DR   CTD; 50515; -.
DR   DisGeNET; 50515; -.
DR   GeneCards; CHST11; -.
DR   HGNC; HGNC:17422; CHST11.
DR   HPA; HPA052828; -.
DR   MIM; 610128; gene.
DR   neXtProt; NX_Q9NPF2; -.
DR   OpenTargets; ENSG00000171310; -.
DR   PharmGKB; PA134875681; -.
DR   eggNOG; KOG4651; Eukaryota.
DR   eggNOG; ENOG4111GJR; LUCA.
DR   GeneTree; ENSGT00760000119214; -.
DR   HOGENOM; HOG000231801; -.
DR   HOVERGEN; HBG050952; -.
DR   InParanoid; Q9NPF2; -.
DR   KO; K01017; -.
DR   OMA; PLNEHWQ; -.
DR   OrthoDB; EOG091G0FZO; -.
DR   PhylomeDB; Q9NPF2; -.
DR   TreeFam; TF325581; -.
DR   BioCyc; MetaCyc:HS10284-MONOMER; -.
DR   BRENDA; 2.8.2.5; 2681.
DR   Reactome; R-HSA-2022870; Chondroitin sulfate biosynthesis.
DR   ChiTaRS; CHST11; human.
DR   GeneWiki; CHST11; -.
DR   GenomeRNAi; 50515; -.
DR   PRO; PR:Q9NPF2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000171310; -.
DR   CleanEx; HS_CHST11; -.
DR   ExpressionAtlas; Q9NPF2; baseline and differential.
DR   Genevisible; Q9NPF2; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0047756; F:chondroitin 4-sulfotransferase activity; IDA:UniProtKB.
DR   GO; GO:0001537; F:N-acetylgalactosamine 4-O-sulfotransferase activity; IDA:UniProtKB.
DR   GO; GO:0050659; F:N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity; IEA:Ensembl.
DR   GO; GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro.
DR   GO; GO:0002063; P:chondrocyte development; IEA:Ensembl.
DR   GO; GO:0030206; P:chondroitin sulfate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0048589; P:developmental growth; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0048703; P:embryonic viscerocranium morphogenesis; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0033037; P:polysaccharide localization; IEA:Ensembl.
DR   GO; GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl.
DR   InterPro; IPR018011; Carb_sulfotrans_8-10.
DR   InterPro; IPR005331; Sulfotransferase.
DR   PANTHER; PTHR12137; PTHR12137; 1.
DR   Pfam; PF03567; Sulfotransfer_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Carbohydrate metabolism;
KW   Chromosomal rearrangement; Complete proteome; Glycoprotein;
KW   Golgi apparatus; Membrane; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    352       Carbohydrate sulfotransferase 11.
FT                                /FTId=PRO_0000189664.
FT   TOPO_DOM      1     16       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     17     37       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     38    352       Lumenal. {ECO:0000255}.
FT   NP_BIND     124    130       PAPS. {ECO:0000250}.
FT   NP_BIND     186    194       PAPS. {ECO:0000250}.
FT   CARBOHYD    205    205       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    223    223       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    321    321       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    342    342       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305|PubMed:15628971}.
FT   VAR_SEQ      35     40       SMLHPV -> I (in isoform 2).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_012992.
FT   MUTAGEN     125    125       K->Q: Abolishes enzyme activity but does
FT                                not affect stability of the protein.
FT                                {ECO:0000269|PubMed:15628971}.
FT   MUTAGEN     205    205       N->S: Induces a weak decrease in enzyme
FT                                activity but has no effect on stability
FT                                of the protein. Unstable protein; when
FT                                associated with S-223 and S-321.
FT                                {ECO:0000269|PubMed:15628971}.
FT   MUTAGEN     223    223       N->S: Induces a weak decrease in enzyme
FT                                activity but has no effect on stability
FT                                of the protein. Unstable protein; when
FT                                associated with S-205 and S-321.
FT                                {ECO:0000269|PubMed:15628971}.
FT   MUTAGEN     321    321       N->S: Induces a strong decrease in enzyme
FT                                activity but has no effect on stability
FT                                of the protein. Unstable protein; when
FT                                associated with S-205 and S-223.
FT   MUTAGEN     342    342       N->S: Induces a strong decrease in enzyme
FT                                activity has no effect on stability of
FT                                the protein.
FT                                {ECO:0000269|PubMed:15628971}.
FT   CONFLICT    289    289       V -> F (in Ref. 3; CAB87380).
FT                                {ECO:0000305}.
SQ   SEQUENCE   352 AA;  41555 MW;  55DF1D29D6703307 CRC64;
     MKPALLEVMR MNRICRMVLA TCLGSFILVI FYFQSMLHPV MRRNPFGVDI CCRKGSRSPL
     QELYNPIQLE LSNTAVLHQM RRDQVTDTCR ANSATSRKRR VLTPNDLKHL VVDEDHELIY
     CYVPKVACTN WKRLMMVLTG RGKYSDPMEI PANEAHVSAN LKTLNQYSIP EINHRLKSYM
     KFLFVREPFE RLVSAYRNKF TQKYNISFHK RYGTKIIKRQ RKNATQEALR KGDDVKFEEF
     VAYLIDPHTQ REEPFNEHWQ TVYSLCHPCH IHYDLVGKYE TLEEDSNYVL QLAGVGSYLK
     FPTYAKSTRT TDEMTTEFFQ NISSEHQTQL YEVYKLDFLM FNYSVPSYLK LE
//
